نتایج جستجو برای: hiv fusion inhibitors

تعداد نتایج: 504964  

2017
Ping Cao Guifang Dou Yuanguo Cheng Jinjing Che

Most mechanistic studies on human immunodeficiency virus (HIV) peptide fusion inhibitors have focused on the interactions between fusion inhibitors and viral envelope proteins. However, the interactions of fusion inhibitors with viral membranes are also essential for the efficacy of these drugs. Here, we utilized surface plasmon resonance (SPR) technology to study the interactions between the H...

Journal: :Cell 2007
Jan Münch Ludger Ständker Knut Adermann Axel Schulz Michael Schindler Raghavan Chinnadurai Stefan Pöhlmann Chawaree Chaipan Thorsten Biet Thomas Peters Bernd Meyer Dennis Wilhelm Hong Lu Weiguo Jing Shibo Jiang Wolf-Georg Forssmann Frank Kirchhoff

A variety of molecules in human blood have been implicated in the inhibition of HIV-1. However, it remained elusive which circulating natural compounds are most effective in controlling viral replication in vivo. To identify natural HIV-1 inhibitors we screened a comprehensive peptide library generated from human hemofiltrate. The most potent fraction contained a 20-residue peptide, designated ...

2012
Martin S. Hirsch

4 Optimal HIV-1 suppression often is difficult to achieve and maintain with currently available antiretroviral drugs, and viral resistance eventually emerges to many drugs. Chronic antiretroviral therapy is also associated with complications such as body fat redistribution, hypertriglyceridemia and hypercholesterolemia, abnormal glucose metabolism, lactic acidosis, pancreatitis, avascular necro...

Journal: :journal of research in medical sciences 0
alireza abdollahi saeed shoar siroos jafari nasrin shoar

background: our study aimed to determine if alteration of metabolic parameters is associated with the severity of human immunodeficiency virus (hiv) infection, progress to acquired immunodeficiency syndrome (aids), or with the type of antiretroviral treatment (art).materials and methods: in a cross-sectional study among 114 hiv infected patients, we measured hematological and biochemical parame...

2015
Hui Liu Xiaomiao Shi Dongmei Guo Zuowei Zhao Yimin

It is crucial to understand the specificity of HIV-1 protease for designing HIV-1 protease inhibitors. In this paper, a new feature selection method combined with neural network structure optimization is proposed to analyze the specificity of HIV-1 protease and find the important positions in an octapeptide that determined its cleavability. Two kinds of newly proposed features based on Amino Ac...

Journal: :Journal of virology 2012
Xiaowen Yu Lu Lu Lifeng Cai Pei Tong Suiyi Tan Peng Zou Fanxia Meng Ying-Hua Chen Shibo Jiang

To prove that the peptidic HIV-1 fusion inhibitors containing the pocket-binding domain (PBD) mainly target the hydrophobic pocket in the gp41 N-terminal heptad repeat (NHR), we constructed pseudoviruses by replacement of Q64 in the gp41 pocket region with Ala (Q64A) or Leu (Q64L). These viruses were highly resistant to C34 and CP32M containing the PBD, while they were susceptible to T20 (enfuv...

Journal: :Current HIV research 2007
Eriketi Zeinalipour-Loizidou Christos Nicolaou Athanasios Nicolaides Leondios G Kostrikis

AIDS has claimed the lives of 25 million people worldwide, an additional 40 million people are HIV-infected and new cases are being diagnosed every year. Despite the fact that HAART has moved AIDS from the category of terminal diseases to that of treatable chronic illnesses, its long-term therapeutic success may be compromised by the development of resistance to the currently used drugs. Despit...

2012

Inhibition of HIV replication initially targeted viral enzymes, which are exclusively expressed by the virus and not present in the human cell. The development of reverse transcriptase (RT) inhibitors started with the discovery of antiretroviral activity of the nucleoside analog zidovudine in March 1987. Currently, six major classes of antiretroviral drugs are used for the treatment of HIV-infe...

Journal: :The Biochemical journal 2005
Florestan Desmaris David Lemaire Sylvie Ricard-Blum Benoît Chatrenet Eric Forest

In the fight against the human HIV, new targets are being explored, such as the proteins involved in the process of fusion of the virus with the host cell. Recently, the first generation of fusion inhibitors (enfuvirtide), targeting gp41 (virus envelope glycoprotein 41), has become commercially available. However, this promising class of drugs has to be improved in respect of their efficacy and...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید